Cargando…
P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430986/ http://dx.doi.org/10.1097/01.HS9.0000971496.22300.69 |
| _version_ | 1785091091186319360 |
|---|---|
| author | Zhou, Hui LI, Yajun Zeng, Ruolan He, Yizi |
| author_facet | Zhou, Hui LI, Yajun Zeng, Ruolan He, Yizi |
| author_sort | Zhou, Hui |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430986 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309862023-08-17 P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA Zhou, Hui LI, Yajun Zeng, Ruolan He, Yizi Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430986/ http://dx.doi.org/10.1097/01.HS9.0000971496.22300.69 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhou, Hui LI, Yajun Zeng, Ruolan He, Yizi P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA |
| title | P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA |
| title_full | P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA |
| title_fullStr | P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA |
| title_full_unstemmed | P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA |
| title_short | P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA |
| title_sort | p1150: a prospective phase ii clinical trial using chidamide, tislelizumab, and pegaspargase in combination with radiotherapy as first-line treatment in stages i/ii of extranodal nk/t-cell lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430986/ http://dx.doi.org/10.1097/01.HS9.0000971496.22300.69 |
| work_keys_str_mv | AT zhouhui p1150aprospectivephaseiiclinicaltrialusingchidamidetislelizumabandpegaspargaseincombinationwithradiotherapyasfirstlinetreatmentinstagesiiiofextranodalnktcelllymphoma AT liyajun p1150aprospectivephaseiiclinicaltrialusingchidamidetislelizumabandpegaspargaseincombinationwithradiotherapyasfirstlinetreatmentinstagesiiiofextranodalnktcelllymphoma AT zengruolan p1150aprospectivephaseiiclinicaltrialusingchidamidetislelizumabandpegaspargaseincombinationwithradiotherapyasfirstlinetreatmentinstagesiiiofextranodalnktcelllymphoma AT heyizi p1150aprospectivephaseiiclinicaltrialusingchidamidetislelizumabandpegaspargaseincombinationwithradiotherapyasfirstlinetreatmentinstagesiiiofextranodalnktcelllymphoma |